Derivation Web

v0.1 · api

Chain for claim_89b20875440641b4

8 nodes. Root first; inputs below.

depth 0 · claim · via classify
claim_89b20875440641b4
# Research Synthesis: Semaglutide Cardiovascular Effects — full paper

## Abstract

Evidence-honesty note: 15/16 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated significant wei…
sha256 f48e2333d50d40ff…
depth 1 · source
source_748ac329d15549a0
# Research Synthesis: Semaglutide Cardiovascular Effects — full paper

## Abstract

Evidence-honesty note: 15/16 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated significant wei…
sha256 db18fca9767bec58…
depth 1 · source
source_183cece3d73743b5
{"publication_id": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "traces": [{"candidate_sources": [{"doi": "10.1186/s12916-025-04486-0", "study": "The adverse effects associated with semaglutide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis", "url": "https://doi.org/10.1186/s12916-025-04486-0"}, {"doi": "10.1038/s41591-02…
sha256 1145e5a211bca26a…
depth 1 · source
source_853916b79fb4474a
{"content_hash": null, "edges": [{"from": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "to": "claim_1", "type": "contains_claim"}, {"from": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "to": "claim_2", "type": "contains_claim"}, {"from": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "to": "claim_3", "type": "contains_claim"}, {"from": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "to": "claim_4", "type": "contains_clai…
sha256 77057f6c59b2f3be…
depth 1 · source
source_168ca8e2ba7e4edc
{"contradictions": ["However, evidence regarding all-cause mortality remains mixed, with one meta-analysis reporting beneficial effects (Sillassen 2025) while a comparative analysis in patients with heart failure with preserved ejection fraction found no significant difference between semaglutide and tirzepatide (Abstract 2025).", "The geroscience hypothesis proposes that targeting fundamental agi…
sha256 015eab230adda188…
depth 1 · source
source_42ca9f5207c54053
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
The adverse effects associated with semaglutide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
A systematic …
sha256 a0cac2de71917afe…
depth 1 · source
source_bbe885e848434640
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "f1c01d83-4fcb-4727-ae92-1f10f78503a4", "sources": [{"directness": "review-level", "doi": "10.1186/s12916-025-04486-0", "risk_of_bias": "not appraised in public sidecar", "study": "The adverse effects associated with semaglutide use in pa…
sha256 afa3d89f3b14f425…
depth 1 · source
source_de8ea040d2a24b72
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 6dd2e7f333e55379…